Stockreport

Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance [Yahoo! Finance]

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Net Loss : Recorded a net loss of $(138.4) million for the year, attributed to valuation adjustments and decreased demand. Adjusted EBITDA Margin : Achieved 23% for t [Read more]